MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 197 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $786,340 | -19.2% | 109,824 | -2.1% | 0.00% | 0.0% |
| Q1 2024 | $972,653 | +25.7% | 112,186 | -5.1% | 0.00% | 0.0% |
| Q4 2023 | $774,059 | -37.3% | 118,177 | -4.3% | 0.00% | -50.0% |
| Q3 2023 | $1,235,130 | -26.6% | 123,513 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $1,683,445 | -17.9% | 135,434 | -7.5% | 0.00% | -33.3% |
| Q1 2023 | $2,050,209 | -3.4% | 146,339 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $2,123,404 | -43.3% | 148,386 | +1.2% | 0.00% | -50.0% |
| Q3 2022 | $3,744,000 | -14.1% | 146,666 | -4.4% | 0.01% | -14.3% |
| Q2 2022 | $4,360,000 | -19.3% | 153,463 | +0.2% | 0.01% | 0.0% |
| Q1 2022 | $5,400,000 | -22.1% | 153,104 | -7.4% | 0.01% | -12.5% |
| Q4 2021 | $6,931,000 | -26.0% | 165,423 | -13.3% | 0.01% | -33.3% |
| Q3 2021 | $9,361,000 | +70.8% | 190,724 | +45.2% | 0.01% | +71.4% |
| Q2 2021 | $5,482,000 | +28.4% | 131,360 | +9.7% | 0.01% | +16.7% |
| Q1 2021 | $4,269,000 | – | 119,785 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |